Company Filing History:
Years Active: 2025
Title: Innovations of Ted Douglas Monchamp
Introduction
Ted Douglas Monchamp is an accomplished inventor based in Nashua, NH (US). He has made significant contributions to the field of machine learning and its applications in biological data analysis. His innovative work focuses on synthesizing perturbation data to enhance graphical user interfaces.
Latest Patents
Monchamp holds a patent for a groundbreaking invention titled "Utilizing machine learning models to synthesize perturbation data to generate perturbation heatmap graphical user interfaces." This patent describes systems, non-transitory computer-readable media, and methods for embedding perturbation data via a machine learning model. The invention filters, aligns, and aggregates the embeddings to create a genome-wide perturbation database for real-time generation of perturbation heatmaps. The systems can receive a variety of perturbation images portraying cells from multiple wells corresponding to various cell perturbations. Utilizing a machine learning model, the systems generate well-level image embeddings and align them to produce aligned well-level image embeddings. Furthermore, the systems aggregate these embeddings according to perturbations from one or more experiments to generate perturbation-level image embeddings, enabling effective perturbation comparisons.
Career Highlights
Monchamp is currently employed at Recursion Pharmaceuticals, Inc., where he applies his expertise in machine learning to advance the company's research initiatives. His work is pivotal in developing innovative solutions that leverage technology to improve biological research and data analysis.
Collaborations
Monchamp collaborates with talented individuals such as Marta Marie Fay and August Orvis Allen, contributing to a dynamic and innovative work environment.
Conclusion
Ted Douglas Monchamp's contributions to the field of machine learning and biological data analysis exemplify the impact of innovation in modern science. His patent and work at Recursion Pharmaceuticals, Inc. highlight his commitment to advancing technology for real-world applications.